Focus: Quadriga BioSciences is a clinical-stage oncology biotech focused on developing first-in-class chemotherapeutic agents, based in Los Altos, CA. The company is in early-to-mid development phase with a pipeline targeting CNS and breast cancer indications.
Profile data last refreshed 16h ago · AI intelligence enriched 1w ago
Best suited for early-career scientists or entrepreneurial-minded professionals seeking high-impact roles in a small, pre-revenue oncology biotech with meaningful intellectual ownership but elevated financial risk.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Quadriga BioSciences
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Quadriga BioSciences's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles